237 related articles for article (PubMed ID: 36512300)
21. Comparison of the effects of acylation and amidation on the antimicrobial and antiviral properties of lactoferrin.
Pan Y; Wan J; Roginski H; Lee A; Shiell B; Michalski WP; Coventry MJ
Lett Appl Microbiol; 2007 Mar; 44(3):229-34. PubMed ID: 17309497
[TBL] [Abstract][Full Text] [Related]
22. Sulfonate modified Lactoferrin nanoparticles as drug carriers with dual activity against HIV-1.
Senapathi J; Bommakanti A; Mallepalli S; Mukhopadhyay S; Kondapi AK
Colloids Surf B Biointerfaces; 2020 Jul; 191():110979. PubMed ID: 32276212
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.
Wakabayashi H; Yamauchi K; Kobayashi T; Yaeshima T; Iwatsuki K; Yoshie H
Antimicrob Agents Chemother; 2009 Aug; 53(8):3308-16. PubMed ID: 19451301
[TBL] [Abstract][Full Text] [Related]
24. Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
Narayana RVL; Jana P; Tomar N; Prabhu V; Nair RM; Manukonda R; Kaliki S; Coupland SE; Alexander J; Kalirai H; Kondapi AK; Vemuganti GK
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):13. PubMed ID: 34784412
[TBL] [Abstract][Full Text] [Related]
25. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
26. Preparation, optimization and characterization of bovine lactoferrin-loaded liposomes and solid lipid particles modified by hydrophilic polymers using factorial design.
Yao X; Bunt C; Cornish J; Quek SY; Wen J
Chem Biol Drug Des; 2014 May; 83(5):560-75. PubMed ID: 24325576
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles.
Xia X; Liu H; Lv H; Zhang J; Zhou J; Zhao Z
Drug Des Devel Ther; 2017; 11():1417-1427. PubMed ID: 28533680
[TBL] [Abstract][Full Text] [Related]
28. Nanoformulation of lactoferrin potentiates its activity and enhances novel biotechnological applications.
El-Fakharany EM
Int J Biol Macromol; 2020 Dec; 165(Pt A):970-984. PubMed ID: 33011258
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and self-assembly of curcumin-modified amphiphilic polymeric micelles with antibacterial activity.
Barros CHN; Hiebner DW; Fulaz S; Vitale S; Quinn L; Casey E
J Nanobiotechnology; 2021 Apr; 19(1):104. PubMed ID: 33849570
[TBL] [Abstract][Full Text] [Related]
30. Lactoferrin: an overview of its main functions, immunomodulatory and antimicrobial role, and clinical significance.
Sienkiewicz M; Jaśkiewicz A; Tarasiuk A; Fichna J
Crit Rev Food Sci Nutr; 2022; 62(22):6016-6033. PubMed ID: 33685299
[TBL] [Abstract][Full Text] [Related]
31. Coupling Hydroxyapatite Nanocrystals with Lactoferrin as a Promising Strategy to Fine Regulate Bone Homeostasis.
Montesi M; Panseri S; Iafisco M; Adamiano A; Tampieri A
PLoS One; 2015; 10(7):e0132633. PubMed ID: 26148296
[TBL] [Abstract][Full Text] [Related]
32. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
Thorn CR; Thomas N; Boyd BJ; Prestidge CA
Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
[TBL] [Abstract][Full Text] [Related]
33. Lactoferrin: structure, function and applications.
González-Chávez SA; Arévalo-Gallegos S; Rascón-Cruz Q
Int J Antimicrob Agents; 2009 Apr; 33(4):301.e1-8. PubMed ID: 18842395
[TBL] [Abstract][Full Text] [Related]
34. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Bovine Lactoferrin Nanoparticle Prepared by Desolvation Technique.
Taguchi K; Chuang VTG; Hashimoto M; Nakayama M; Sakuragi M; Enoki Y; Nishi K; Matsumoto K; Seo H; Otagiri M; Yamasaki K
Chem Pharm Bull (Tokyo); 2020; 68(8):766-772. PubMed ID: 32741918
[TBL] [Abstract][Full Text] [Related]
36. Solid lipid nanocarriers in drug delivery: characterization and design.
Mu H; Holm R
Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
38. Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.
Yan X; Xu L; Bi C; Duan D; Chu L; Yu X; Wu Z; Wang A; Sun K
Int J Nanomedicine; 2018; 13():273-281. PubMed ID: 29391788
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
[TBL] [Abstract][Full Text] [Related]
40. Native and thermally modified protein-polyphenol coassemblies: lactoferrin-based nanoparticles and submicrometer particles as protective vehicles for (-)-epigallocatechin-3-gallate.
Yang W; Xu C; Liu F; Yuan F; Gao Y
J Agric Food Chem; 2014 Nov; 62(44):10816-27. PubMed ID: 25310084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
